Penicillin V API
Bacterial Infections
CommercialActive
Key Facts
About Biotika
Biotika is a long-established European API manufacturer with over 70 years of operational history, headquartered in Bratislava, Slovakia. Its core business is the biotechnological fermentation and production of established antibiotic APIs, specifically penicillin V and polymyxin B sulfate, which it exports globally. The company complements its proprietary manufacturing with contract development and manufacturing organization (CDMO) services, focusing on scale-up and process optimization for biotechnological products. Operating under stringent EU (EMA) and US (FDA) GMP standards, Biotika is a specialized, revenue-generating player in the generic antibiotic and niche anti-infective supply chain.
View full company profileTherapeutic Areas
Other Bacterial Infections Drugs
| Drug | Company | Phase |
|---|---|---|
| Novel Antibiotics | Shionogi | Various |
| Anti-infectives Portfolio | Aurobindo Pharma | Commercial |
| Azithromycin products | Alkem Laboratories | Commercial |
| Cefixime & Ofloxacin combinations | Ipca Laboratories | Commercial |
| Antibiotic Portfolio | SPIMACO | Approved/Commercial |
| Zevtera® (ceftobiprole medocaril) | Basilea Pharmaceutica | Approved/Commercial |
| Cephalosporin APIs (Cefixime, Cefpodoxime, etc.) | Nectar Lifesciences | Approved |
| Penicillin APIs (Amoxicillin, etc.) | Nectar Lifesciences | Approved |
| Vibativ® (telavancin) | Cleo Life Sciences | Approved |